# HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients

> **NCT05550662** · PHASE2 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 6 (actual)

## Conditions studied

- Lung Transplant Rejection

## Interventions

- **DRUG:** 129Xenon

## Key facts

- **NCT ID:** NCT05550662
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-07
- **Primary completion:** 2024-08-02
- **Final completion:** 2024-08-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Recruitment challenges
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05550662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05550662, "HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05550662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*